Year: 2022
Type: article
Abstract: Editor, Approximately 103,800 people in the UK are living with human immunodeficiency virus (HIV) as a chronic disease, reflecting the major impact of highly active antiretroviral therapy (HAART).Physicians will be familiar with links between HIV and acute coronary events 1, 2 but may be less familiar with potential interactions between HAART and cardiovascular medication.We describe a patient living with HIV who underwent primary percutaneous coronary intervention (PPCI) with stent implantation for acute myocardial infarction, along with some important therapeutic considerations that were required to optimise his cardiovascular prognosis.
Source: PubMed Central
Institution: Altnagelvin Area Hospital
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4311576960
